ClinicalTrials.Veeva

Menu

Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Terminated

Conditions

Cognitive Impairment
Driving Habits Patients

Treatments

Behavioral: ACCOMPAGNE Education Program
Behavioral: Usuals recommandations

Study type

Interventional

Funder types

Other

Identifiers

NCT04493957
69HCL19_0676

Details and patient eligibility

About

ACCOMPAGNE study proposes to evaluate an educational program for the patient / caregiver dyad, intended to accompany the patient towards the implementation of self-regulation strategies in the driving activity. The program, based on group workshops with the presence of the patient and the caregiver, is led by an interdisciplinary team. It follows all the intervention recommendations described in the literature: to make the patient a decision-maker, to allow advanced planning of discussions between the family member and the caregiver, to give information on the consequences of TNCs and sensory disorders. This program provides psychological support in the management of the problems and the mourning of a future cessation of the driving activity, an awareness of the risky and avoidable situations, information on alternative solutions and available resources in the event of reduced driving. The program is created to support the implementation of self-regulation strategies for safe driving and a gradual reduction of driving activity. This study may be included in Measure 5 of the Neuro-Degenerative Diseases Plan (PMND) 2014-2019. This plan recommends to strengthen the self-management of patients and their relatives in the disease.

Enrollment

10 patients

Sex

All

Ages

50 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged between 50 and 95 years-old
  • hold a driving license,
  • drive at least twice a week,
  • to have given free and informed consent,
  • present a diagnosis of major or minor CNS according to DSM V, whose clinically probable or definite etiology is Alzheimer's or related or vascular disease,
  • have a result in the Mini Mental State Examination (MMSE) greater than 18,
  • have the ability to speak orally enough or write enough to perform clinical evaluations and workshops, be accompanied by a family member present at least 4 hours a week.

Criteria for inclusion of carers:

  • to be a caregiver helping the patient for activities of daily living,
  • to have given their free and informed consent,
  • have the ability to speak orally and write enough to perform clinical assessments.

Exclusion criteria

  • have a major psychiatric history, history of alcoholism, anti-depressant
  • have sensory problems preventing participation in workshops,
  • be affected by any debilitating pathology compromising the health of the patient in the short and medium term,
  • be unable to express consent. Criteria for non-inclusion of caregivers: have sensory disturbances preventing participation in workshops.

Recruited patients and caregivers should have been informed and signed a consent.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

10 participants in 2 patient groups

educational intervention
Experimental group
Description:
Patients and caregivers included in the "ACCOMPAGNE Education Program" group will benefit from seven group workshops spread over three half-days (once a week over 3 consecutive weeks), animated in pairs, each lasting approximately one and a half hours. and using educational pedagogical methods.
Treatment:
Behavioral: ACCOMPAGNE Education Program
Control group
Active Comparator group
Description:
Patients and caregivers included in the "Control" group will receive the usual recommendations for driving, issued by their referring doctor in memory consultation during the diagnostic announcement process or during the follow-up of their illness.
Treatment:
Behavioral: Usuals recommandations

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems